sdz pco 400 has been researched along with Autoimmune Diabetes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bast, JP; Carmines, PK; Fallet, RW; Ikenaga, H | 1 |
1 other study(ies) available for sdz pco 400 and Autoimmune Diabetes
| Article | Year |
|---|---|
Exaggerated impact of ATP-sensitive K(+) channels on afferent arteriolar diameter in diabetes mellitus.
Topics: Adenosine Triphosphate; Animals; Arterioles; Benzopyrans; Cyclopentanes; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glyburide; Hypoglycemic Agents; Male; Pinacidil; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Sprague-Dawley; Vasodilator Agents; Vasomotor System | 2000 |